rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses
- Resource Type
- article
- Source
- Retrovirology, Vol 9, Iss Suppl 2, p O72 (2012)
- Subject
Immunologic diseases. Allergy RC581-607 - Language
- English
- ISSN
- 1742-4690